Table of Contents

- M P Golden
Incorporation of quality-of-life considerations into intensive diabetes management protocols in adolescents.
Diabetes Care June 1998 21:885-886; doi:10.2337/diacare.21.6.885
- D R Coustan
Pre-conception planning. The relationship's the thing.
Diabetes Care June 1998 21:887-888; doi:10.2337/diacare.21.6.887
- Full Text (PDF)
Select this article
- E V Holing,
- C S Beyer,
- Z A Brown,
- and F A Connell
Why don't women with diabetes plan their pregnancies?
Diabetes Care June 1998 21:889-895; doi:10.2337/diacare.21.6.889
- Abstract
- Full Text (PDF)
Select this article
- P H Noël,
- A C Larme,
- J Meyer,
- G Marsh,
- A Correa,
- and J A Pugh
Patient choice in diabetes education curriculum. Nutritional versus standard content for type 2 diabetes.
Diabetes Care June 1998 21:896-901; doi:10.2337/diacare.21.6.896
- Abstract
- Full Text (PDF)
Select this article
- M Grey,
- E A Boland,
- M Davidson,
- C Yu,
- S Sullivan-Bolyai,
- and W V Tamborlane
Short-term effects of coping skills training as adjunct to intensive therapy in adolescents.
Diabetes Care June 1998 21:902-908; doi:10.2337/diacare.21.6.902
- Abstract
- Full Text (PDF)
Select this article
- M Grey,
- E A Boland,
- C Yu,
- S Sullivan-Bolyai,
- and W V Tamborlane
Personal and family factors associated with quality of life in adolescents with diabetes.
Diabetes Care June 1998 21:909-914; doi:10.2337/diacare.21.6.909
- Abstract
- Full Text (PDF)
Select this article
- I Guttmann-Bauman,
- B P Flaherty,
- M Strugger,
- and R C McEvoy
Metabolic control and quality-of-life self-assessment in adolescents with IDDM.
Diabetes Care June 1998 21:915-918; doi:10.2337/diacare.21.6.915
- Abstract
- Full Text (PDF)
Select this article
- J J de Sonnaville,
- F J Snoek,
- L P Colly,
- W Devillé,
- D Wijkel,
- and R J Heine
Well-being and symptoms in relation to insulin therapy in type 2 diabetes.
Diabetes Care June 1998 21:919-924; doi:10.2337/diacare.21.6.919
- Abstract
- Full Text (PDF)
Select this article
- D Fava,
- S Gardner,
- D Pyke,
- and R D Leslie
Evidence that the age at diagnosis of IDDM is genetically determined.
Diabetes Care June 1998 21:925-929; doi:10.2337/diacare.21.6.925
- Abstract
- Full Text (PDF)
Select this article
- T Petterson,
- P Lee,
- S Hollis,
- B Young,
- P Newton,
- and T Dornan
Well-being and treatment satisfaction in older people with diabetes.
Diabetes Care June 1998 21:930-935; doi:10.2337/diacare.21.6.930
- Abstract
- Full Text (PDF)
Select this article
- F al-Mahroos and
- P M McKeigue
High prevalence of diabetes in Bahrainis. Associations with ethnicity and raised plasma cholesterol.
Diabetes Care June 1998 21:936-942; doi:10.2337/diacare.21.6.936
- Abstract
- Full Text (PDF)
Select this article
- H F Allen,
- E C Gay,
- G J Klingensmith,
- and R F Hamman
Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S.
Diabetes Care June 1998 21:943-948; doi:10.2337/diacare.21.6.943
- Abstract
- Full Text (PDF)
Select this article
- T Valle,
- J Tuomilehto,
- R N Bergman,
- S Ghosh,
- E R Hauser,
- J Eriksson,
- S J Nylund,
- K Kohtamäki,
- L Toivanen,
- G Vidgren,
- E Tuomilehto-Wolf,
- C Ehnholm,
- J Blaschak,
- C D Langefeld,
- R M Watanabe,
- V Magnuson,
- D S Ally,
- W A Hagopian,
- E Ross,
- T A Buchanan,
- F Collins,
- and M Boehnke
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study.
Diabetes Care June 1998 21:949-958; doi:10.2337/diacare.21.6.949
- Abstract
- Full Text (PDF)
Select this article
- R D Lindeman,
- L J Romero,
- R Hundley,
- A S Allen,
- H C Liang,
- R N Baumgartner,
- K M Koehler,
- D S Schade,
- and P J Garry
Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population.
Diabetes Care June 1998 21:959-966; doi:10.2337/diacare.21.6.959
- Abstract
- Full Text (PDF)
Select this article
- A Ramachandran,
- C Snehalatha,
- E Latha,
- K Satyavani,
- and V Vijay
Clustering of cardiovascular risk factors in urban Asian Indians.
Diabetes Care June 1998 21:967-971; doi:10.2337/diacare.21.6.967
- Abstract
- Full Text (PDF)
Select this article
- S A Smith,
- M E Murphy,
- T R Huschka,
- S F Dinneen,
- C A Gorman,
- B R Zimmerman,
- R A Rizza,
- and J M Naessens
Impact of a diabetes electronic management system on the care of patients seen in a subspecialty diabetes clinic.
Diabetes Care June 1998 21:972-976; doi:10.2337/diacare.21.6.972
- Abstract
- Full Text (PDF)
Select this article
- V Melki,
- E Renard,
- V Lassmann-Vague,
- S Boivin,
- B Guerci,
- H Hanaire-Broutin,
- J Bringer,
- P Belicar,
- N Jeandidier,
- L Meyer,
- P Blin,
- B Augendre-Ferrante,
- and J P Tauber
Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.
Diabetes Care June 1998 21:977-982; doi:10.2337/diacare.21.6.977
- Abstract
- Full Text (PDF)
Select this article
- W L Roberts,
- M McCraw,
- and C B Cook
Effects of sickle cell trait and hemoglobin C trait on determinations of HbA1c by an immunoassay method.
Diabetes Care June 1998 21:983-986; doi:10.2337/diacare.21.6.983
- Abstract
- Full Text (PDF)
Select this article
- R G Thompson,
- L Pearson,
- S L Schoenfeld,
- and O G Kolterman
Pramlintide, a synthetic analog of human amylin, improves the metabolic profile of patients with type 2 diabetes using insulin. The Pramlintide in Type 2 Diabetes Group.
Diabetes Care June 1998 21:987-993; doi:10.2337/diacare.21.6.987
- Abstract
- Full Text (PDF)
Select this article
- E Werle,
- W Fiehn,
- and C Hasslacher
Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients.
Diabetes Care June 1998 21:994-998; doi:10.2337/diacare.21.6.994
- Abstract
- Full Text (PDF)
Select this article
- M T García-Unzueta,
- C Montalbán,
- C Pesquera,
- J R Berrazueta,
- and J A Amado
Plasma adrenomedullin levels in type 1 diabetes. Relationship with clinical parameters.
Diabetes Care June 1998 21:999-1003; doi:10.2337/diacare.21.6.999
- Abstract
- Full Text (PDF)
Select this article
- M Peppa-Patrikiou,
- M Scordili,
- A Antoniou,
- M Giannaki,
- M Dracopoulou,
- and C Dacou-Voutetakis
Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol, and other factors.
Diabetes Care June 1998 21:1004-1007; doi:10.2337/diacare.21.6.1004
- Abstract
- Full Text (PDF)
Select this article
- J P Albertini,
- P Valensi,
- B Lormeau,
- M H Aurousseau,
- F Ferrière,
- J R Attali,
- and L Gattegno
Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment.
Diabetes Care June 1998 21:1008-1013; doi:10.2337/diacare.21.6.1008
- Abstract
- Full Text (PDF)
Select this article
- Y Hamada,
- C Nishimura,
- N Koh,
- F Sakakibara,
- J Nakamura,
- T Tanimoto,
- and N Hotta
Influence of interindividual variability of aldose reductase protein content on polyol-pathway metabolites and redox state in erythrocytes in diabetic patients.
Diabetes Care June 1998 21:1014-1018; doi:10.2337/diacare.21.6.1014
- Abstract
- Full Text (PDF)
Select this article
- L Barkai,
- I Vámosi,
- and K Lukács
Enhanced progression of urinary albumin excretion in IDDM during puberty.
Diabetes Care June 1998 21:1019-1023; doi:10.2337/diacare.21.6.1019
- Abstract
- Full Text (PDF)
- Z T Bloomgarden
International Diabetes Federation meeting, 1997. Issues in the treatment of type 2 diabetes; sulfonylureas, metformin, and troglitazone.
Diabetes Care June 1998 21:1024-1026; doi:10.2337/diacare.21.6.1024
- Full Text (PDF)
- Y Ono,
- S Aoki,
- K Ohnishi,
- T Yasuda,
- K Kawano,
- and Y Tsukada
Increased serum levels of advanced glycation end products in NIDDM patients with diabetic complications.
Diabetes Care June 1998 21:1027; doi:10.2337/diacare.21.6.1027b
- Full Text (PDF)
- C A Aguilar-Salinas,
- E García-García,
- I Lerman-Garber,
- F J Gómez-Pérez,
- and J A Rull
Making things easier is not so easy. The 1997 American Diabetes Association criteria and glucose intolerance.
Diabetes Care June 1998 21:1027-1028; doi:10.2337/diacare.21.6.1027a
- Full Text (PDF)
- V A Fonseca,
- T Reynolds,
- and L M Fink
Hyperhomocysteinemia and microalbuminuria in diabetes.
Diabetes Care June 1998 21:1028; doi:10.2337/diacare.21.6.1028
- Full Text (PDF)
- P Iglesias,
- A Ferreira,
- and J J Diez
Common variable immunodeficiency in adult woman with IDDM.
Diabetes Care June 1998 21:1029; doi:10.2337/diacare.21.6.1029b
- Full Text (PDF)
- P E Knudson,
- K J Turner,
- A Sedore,
- and R S Weinstock
Utility of the American Diabetes Association risk test in a community screening program.
Diabetes Care June 1998 21:1029-1031; doi:10.2337/diacare.21.6.1029a
- Full Text (PDF)
- N Pitteloud,
- K Binz,
- A Caulfield,
- and J Philippe
Ketoacidosis during gestational diabetes. Case report.
Diabetes Care June 1998 21:1031-1032; doi:10.2337/diacare.21.6.1031
- Full Text (PDF)

Incorporation of quality-of-life considerations into intensive diabetes management protocols in adolescents.

Pre-conception planning. The relationship's the thing.

Why don't women with diabetes plan their pregnancies?

Patient choice in diabetes education curriculum. Nutritional versus standard content for type 2 diabetes.

Short-term effects of coping skills training as adjunct to intensive therapy in adolescents.

Personal and family factors associated with quality of life in adolescents with diabetes.

Metabolic control and quality-of-life self-assessment in adolescents with IDDM.

Well-being and symptoms in relation to insulin therapy in type 2 diabetes.

Evidence that the age at diagnosis of IDDM is genetically determined.

Well-being and treatment satisfaction in older people with diabetes.

High prevalence of diabetes in Bahrainis. Associations with ethnicity and raised plasma cholesterol.

Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S.

Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study.

Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population.

Clustering of cardiovascular risk factors in urban Asian Indians.

Impact of a diabetes electronic management system on the care of patients seen in a subspecialty diabetes clinic.

Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.

Effects of sickle cell trait and hemoglobin C trait on determinations of HbA1c by an immunoassay method.

Pramlintide, a synthetic analog of human amylin, improves the metabolic profile of patients with type 2 diabetes using insulin. The Pramlintide in Type 2 Diabetes Group.

Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients.

Plasma adrenomedullin levels in type 1 diabetes. Relationship with clinical parameters.

Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol, and other factors.

Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment.

Influence of interindividual variability of aldose reductase protein content on polyol-pathway metabolites and redox state in erythrocytes in diabetic patients.

Enhanced progression of urinary albumin excretion in IDDM during puberty.

International Diabetes Federation meeting, 1997. Issues in the treatment of type 2 diabetes; sulfonylureas, metformin, and troglitazone.

Increased serum levels of advanced glycation end products in NIDDM patients with diabetic complications.

Making things easier is not so easy. The 1997 American Diabetes Association criteria and glucose intolerance.

Hyperhomocysteinemia and microalbuminuria in diabetes.

Common variable immunodeficiency in adult woman with IDDM.

Utility of the American Diabetes Association risk test in a community screening program.

Ketoacidosis during gestational diabetes. Case report.

This Issue

Current Issue

From the Cover